CSIMarket Company Name, Ticker, Competitors, else..
 
Kestra Medical Technologies Ltd   (NASDAQ: KMTS)
 
Price: $25.7300 $0.61 2.428%
Day's High: $26.49970054626465 Week Perf: -0.31 %
Day's Low: $ 25.09 30 Day Perf: -0.77 %
Volume (M): 245,535 52 Wk High: $ 30.00
Volume (M$): $ 0 52 Wk Avg: $23.71
Open: $25.46 52 Wk Low: $16.32



 Market Capitalization (Millions $) 1,394
 Shares Outstanding (Millions) 54
 Employees -
 Revenues (TTM) (Millions $) 94
 Net Income (TTM) (Millions $) -132
 Cash Flow (TTM) (Millions $) 54
 Capital Exp. (TTM) (Millions $) 48

Business Description


Kestra Medical Technologies, Ltd. was established to complete its initial public offering and did not conduct business activities other than those related to its formation and the IPO process prior to the offering. The company's business was previously operated through West Affum Intermediate Holdings Corp., which became a wholly owned subsidiary of Kestra Medical Technologies, Ltd. in connection with the IPO.


   Company Address: 3933 Lake Washington Blvd NE Kirkland 98033 WA
   Company Phone Number: 279-8002   Stock Exchange / Ticker: NASDAQ KMTS


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
• View Complete Report
   



Product Service News

Defibrillators Unplugged The ASSURE Devices Groundbreaking Validation in Wearable Health Tech,

Published Mon, Nov 10 2025 2:55 PM UTC

Wearable Defibrillators Prove Their Worth: Groundbreaking Study Validates Kestra s ASSURE Device In the fast-evolving landscape of medical technology, wearable devices have steadily emerged as a cornerstone of innovative patient care. Leading this charge in cardiac health is Kestra Medical Technologies, Ltd. (Nasdaq: KMTS), whose ASSURE Wearable Cardioverter Defibrillator (W...
Shares

Kestra Medical Technologies Amplifies IPO with Full Over-Allotment, Securing $232 Million in Total Proceeds,

Published Fri, Mar 14 2025 8:05 PM UTC

Kestra Medical Technologies, Ltd. Expands Initial Public Offering: A New Era for Wearable Health TechKirkland, Wash. March 14, 2025 In a significant boost to its initial public offering (IPO), Kestra Medical Technologies, Ltd. (Kestra), a pioneering company in wearable medical devices and digital healthcare, announced today the full exercise of the over-allotment option ...



Fundamental Analysis

Valuation Current
Price to Earnings PE Ratio (TTM) -
Price to Earnings PE Ratio (Expected) -
Price to Sales (TTM) 14.86
Price to Sales (Expected) -
Price to Book 5.37
PEG (TTM) -

Financial Strength Current
Quick Ratio 3.9
Working Capital Ratio 4.28
Leverage Ratio (MRQ) 0.4
Total Debt to Equity 0.16
Interest Coverage (TTM) -
Debt Coverage (TTM) -

Per Share Current
Earnings (TTM) -2.47 $
Revenues (TTM) 1.73 $
Cash Flow (TTM) 0.99 $
Cash 3.63 $
Book Value 4.79 $
Dividend (TTM) 0 $

Efficiency Current
Revenue per Employee (TTM) -
Net Income per Employee (TTM) -
Receivable Turnover Ratio (TTM) 10.37
Inventory Turnover Ratio (TTM) -
Asset Turnover Ratio (TTM) 0.39

Profitability Ratios Current
Gross Margin (MRQ) 54.76 %
Operating Margin (MRQ) -137.38 %
Net Margin (MRQ) -135.61 %
Net Cash Flow Margin (MRQ) 0 %
Effective Tax Rate (TTM) -

Management Effectiveness Current
Return On Assets (TTM) -
Return On Investment (TTM) -
Return On Equity (TTM) -
Dividend Yield -
Pay out Ratio (TTM) -



Kestra Medical Technologies Ltd's Segments





Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.